Molecular Imaging of Primary Amyloid Cardiomyopathy | stella

Learn Data For Researchers Find trials matched to me

Learn Data For Researchers Find trials matched to me →

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Privacy ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Molecular Imaging of Primary Amyloid Cardiomyopathy | stella

Back to Amyloidosis, Primary trials

Recruiting

Plain-English translation of NCT02641145 on ClinicalTrials.gov ↗ · Source last updated November 2025 · How we translate trials

This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.

Trial locations(1 site)

United States

Brigham and Womens' Hospital, Boston, Massachusetts

Key details

Sponsor

Brigham and Women's Hospital

Collaborators

National Institutes of Health (NIH), National Heart, Lung, and Blood Institute (NHLBI)

Enrollment target

~171 participants

Started

April 2016

Primary completion

December 2027

Age range

18 Years – 99 Years

Last updated on clinicaltrials.gov in November 2025.

Contact the research team directly

Reach out to the team running this trial. Response times vary — some teams are faster than others.

Central contact

Sharmila Dorbala, MD, MPH

Brigham and Women's Hospital (AHA and NIH Studies)

View full record on ClinicalTrials.gov

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.